Centene
About: Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract.
Employees: 67,700
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
13% more funds holding in top 10
Funds holding in top 10: 8 [Q2] → 9 (+1) [Q3]
1% more capital invested
Capital invested by funds: $35B [Q2] → $35.3B (+$366M) [Q3]
3% less funds holding
Funds holding: 879 [Q2] → 857 (-22) [Q3]
9.42% less ownership
Funds ownership: 98.8% [Q2] → 89.38% (-9.42%) [Q3]
14% less repeat investments, than reductions
Existing positions increased: 297 | Existing positions reduced: 347
20% less first-time investments, than exits
New positions opened: 88 | Existing positions closed: 110
29% less call options, than puts
Call options by funds: $223M | Put options by funds: $314M
Research analyst outlook
10 Wall Street Analysts provided 1 year price targets over the past 3 months
10 analyst ratings
Wells Fargo Stephen Baxter 15% 1-year accuracy 3 / 20 met price target | 49%upside $90 | Overweight Maintained | 4 Nov 2024 |
Bernstein Lance Wilkes 100% 1-year accuracy 2 / 2 met price target | 46%upside $88 | Outperform Maintained | 30 Oct 2024 |
Barclays Andrew Mok 44% 1-year accuracy 24 / 55 met price target | 51%upside $91 | Overweight Maintained | 29 Oct 2024 |
Baird Michael Ha 70% 1-year accuracy 7 / 10 met price target | 9%upside $66 | Neutral Maintained | 25 Oct 2024 |
Cantor Fitzgerald Sarah James 35% 1-year accuracy 36 / 102 met price target | 49%upside $90 | Overweight Reiterated | 1 Oct 2024 |
Financial journalist opinion
Based on 28 articles about CNC published over the past 30 days
